Skip to main content
Contact us

Spray Drying CDMO Companies
Oral Solid Dose Spray Drying Services

Specialized Spray Drying Solutions for Oral Solid Dose Pharmaceutical Manufacturing

Showing 5 facilities
Aenova Group - Location Killorglin, Ireland
Ireland

Aenova Group - Location Killorglin, Ireland

Aenova

Competence Center for spray drying and modified release pellets.

MARKETS: EMA (EU), PMDA (Japan), SFDA (Saudi Arabia), MFDS (South Korea)

REGION: Europe

COMPLIANCE: ISO, PMDA/MHLW (Japan GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: NUTRACEUTICALS, FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Adare Pharma | US
United States

Adare Pharma | US

Adare Pharma Solutions

Adare Pharma es un CDMO global con instalaciones en EE.UU. y la UE, que ofrece desarrollo de productos llave en mano mediante experiencia en fabricación comerci

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Halal Research Council, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, French Service-Public (CIR), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

CATEGORY / PRODUCT: SERVICES, FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

Adare Pharma | EU
Italy

Adare Pharma | EU

Adare Pharma Solutions

Global CDMO offering turnkey product development through commercial manufacturing expertise, focused on oral dosage forms.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (A) Digestive tract and metabolism, (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (V01) Allergens

MARKETS: TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE)

COMPLIANCE: French Service-Public (CIR), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Halal Research Council, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention

BATCH SIZE: Small, Medium, Large

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

CATEGORY / PRODUCT: SERVICES, FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

USE: Human, Veterinary

PHARMALOOP S.L. - a Salvat Company
Spain

PHARMALOOP S.L. - a Salvat Company

Laboratorios Salvat

Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.

MARKETS: EMA (EU), FDA (USA)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (S) Sensory organs, (V01) Allergens

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Limited view

COSMETICS manufacturing site

MAI network supplier

Your trusted GMP CDMO for advanced aseptic and non-aseptic pharmaceutical drug product manufacturing, formulation development, and analytical testing.

Location available after registration

Suggested Results

These facilities match your main criteria but not every optional filter — including other countries in the same region.

Limited view

NUTRACEUTICALS manufacturing site

MAI network supplier

An USFDA approved API & Intermediate Manufacturing facility.

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

An API and Interemediate manufacturer having global certifications.

Location available after registration

Limited view

COSMETICS manufacturing site

MAI network supplier

Chemical-Pharmaceutical Facility

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Dry Powder Inhalation Plant.

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Commercial-scale oral solid dosage (OSD) manufacturing facility with strong expertise in controlled substances (DEA II V).

Location available after registration

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Contract manufacturing facility specialized in Oral Solid Dosage (OSD) for clinical and commercial supply.

Location available after registration

Spray drying is a versatile technology widely used in the pharmaceutical industry to produce high-quality oral solid dose (OSD) formulations. By converting liquids, suspensions, or dispersions into powders, spray drying CDMO companies enable improved solubility, enhanced bioavailability, and uniform particle size distribution, critical factors in oral solid dose development.

Experienced oral solid dose spray drying CDMOs provide end-to-end services from formulation optimization and process development to GMP manufacturing of spray-dried powders for tablets, capsules, and multiparticulate systems.

How to Choose Spray Drying CDMO Companies

Selecting the right spray drying CDMO ensures consistent product quality, regulatory compliance, and efficient scale-up. Key factors include:

  • OSD formulation expertise: Proven experience in tablets, capsules, and multiparticulates.
  • Particle engineering capabilities: Control over particle size, morphology, density, and flowability.
  • Solubility and bioavailability enhancement: Advanced amorphous solid dispersions (ASDs) and micronization techniques.
  • Process scalability: Smooth transition from lab-scale to pilot and commercial production.
  • GMP compliance: Facilities and processes aligned with FDA, EMA, and global regulatory standards.
  • Analytical and QC support: Ensuring uniformity, stability, and performance of spray-dried powders.

Key Services Offered by Oral Solid Dose Spray Drying CDMOs

Leading spray drying CDMOs typically provide:

  • Spray drying of amorphous solid dispersions (ASDs) for poorly soluble APIs
  • Micronization and particle size control to improve dissolution and content uniformity
  • Spray-dried powders for tablets, capsules, and multiparticulate systems
  • Formulation optimization and process development
  • GMP manufacturing for clinical and commercial-scale production
  • Comprehensive analytical and quality control for OSD powders

Advantages of Partnering with Spray Drying CDMO Companies

Working with specialized spray drying CDMOs provides multiple benefits for oral solid dose development:

  • Improved solubility and bioavailability for poorly water-soluble APIs
  • Enhanced formulation performance with controlled particle characteristics
  • Regulatory confidence with fully GMP-compliant manufacturing
  • Efficient scale-up: Smooth transfer from lab to commercial scale
  • Reliable global supply chain for OSD powders

Spray Drying CDMO Companies

  • Pharmaloop: Fully integrated CDMO solutions for spray drying, sachets, capsules and tablets. [See CDMO profile]
  • Aenova Group - Killorglin: Competence Center for spray drying and modified release pellets. [See CDMO profile]
  • Ascendia Pharmaceutical Solutions: Your trusted GMP CDMO for advanced aseptic and non-aseptic pharmaceutical drug product manufacturing, formulation development, and analytical testing. [See CDMO profile]

Related Information

Let MAI CDMO Network Help You Find the Right Spray Drying CDMO Partner

At MAI CDMO Network, we connect pharmaceutical and biotech companies with trusted oral solid dose spray drying CDMOs worldwide. Whether your project requires amorphous solid dispersions, particle engineering, or GMP spray drying of OSD powders, we help you identify the right partner with the appropriate expertise and technology.

Need a reliable OSD spray drying partner? Contact us today to find the right CDMO for your formulation and manufacturing needs.